Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Shu (Taipei, Taiwan). The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis. 3341

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of the airway microbiome in nontuberculous mycobacteria disease Source: Eur Respir J, 52 (4) 1800810; 10.1183/13993003.00810-2018 Year: 2018 Non-tuberculous mycobacterial lung disease and COPD Source: Eur Respir Monogr 2015; 69: 172-184 Year: 2015 The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Non-tuberculosis mycobacterium related bronchiectasis is associated with oral commensals in the lower airway Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Chronic infections, bronchiectasis and nontuberculous mycobacteria Source: ERS Course 2018 - Respiratory Infections Year: 2018 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006 From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections Source: Eur Respir J 2004; 24: Suppl. 48, 420s Year: 2004 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Surgery in nontuberculous mycobacteria pulmonary disease Source: Breathe, 14 (4) 288; 10.1183/20734735.027218 Year: 2018 Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease Source: Eur Respir J 2016; 48: 928-931 Year: 2016 Non-tuberculous mycobacterial pulmonary disease Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019 Year: 2019 The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Source: Eur Respir J 2006; 28: 1204-1210 Year: 2006 A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Serial sputum induction in nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 55 (6) 1902196; 10.1183/13993003.02196-2019 Year: 2020 Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy Source: Eur Respir J 2005; 25: 324-328 Year: 2005 Nontuberculous mycobacterial disease in CF Source: ERS course 2015 Year: 2015 Bacterial dysbiosis in pediatric lung diseases such as asthma and CF Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future Year: 2020 Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021